Two Sigma Securities’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86K Buy
+48,593
New +$60.8K 0.01% 1322
2025
Q2
Sell
-12,554
Closed -$21.3K 1648
2025
Q1
$21.3K Buy
+12,554
New +$27.3K ﹤0.01% 1090
2024
Q1
Sell
-69,441
Closed -$41.7K 3119
2023
Q4
$41.7K Buy
+69,441
New +$47.4K ﹤0.01% 2631

Other funds holding ENTX

Two Sigma Securities's ENTX Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Entera Bio (ENTX) in Q2 2026: 48,593 shares worth $86K. The stake represents 0.01% of the portfolio and ranks #1322 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ENTX as recently as Q1 2025.

Two Sigma Securities first reported a position in ENTX in Q4 2023 and has held it in 3 quarters since. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Two Sigma Securities held 48,593 shares of Entera Bio worth $86K as of Q2 2026.
  • Entera Bio was a new Two Sigma Securities position in Q2 2026.
  • Entera Bio made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1322 holding.
  • Two Sigma Securities first reported a position in Entera Bio in Q4 2023 and has held it in 3 quarters since.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.